Cell cycle status of CD34+cells in human fetal bone marrow

被引：9
|
作者：
Koenig, JM [1 ]
Luttge, B [1 ]
Benson, NA [1 ]
Christensen, RD [1 ]
机构：
[1] Univ Florida, Coll Med, Dept Pediat, Div Neonatol, Gainesville, FL 32610 USA
来源：
EARLY HUMAN DEVELOPMENT | 2001年 / 65卷 / 02期
关键词：
cell cycle status; CD34+cells; bone marrow;
D O I：
10.1016/S0378-3782(01)00226-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
We used flow cytometric analysis to determine the cell cycle characteristics of human CD34+ cells from fetal bone marrow (BM), adult BM, and umbilical cord blood (UCB) samples. Fetal BM had three-fold more cells in the S-phase than did adult BM or UCB. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：159 / 163
页数：5
相关论文
共 50 条
  • [21] Human brain endothelial cells (HuBECs) support ex vivo expansion of human cord blood CD34+cells, as well as adult human bone marrow CD34+cells.
    Crook, JL
    Takebe, N
    MacVittie, TJ
    Farese, AM
    Shumaker, JM
    Cheng, XF
    Meisenberg, BR
    [J]. BLOOD, 2003, 102 (11) : 959A - 959A
  • [22] Impact of freeze-thaw on isolation of viable CD34+cells from human cadaveric bone marrow
    Bender, Shannon
    Gu, Dongsheng
    LaFontaine, Michael
    Johnstone, Brian
    Woods, Erik
    [J]. FASEB JOURNAL, 2020, 34
  • [23] Comparative Global Transcriptome Analysis of Bone Marrow Stromal Cells (BMSC), Human Embryonic Stem (hES) Cells and CD34+Cells
    Jin, Ping
    Ren, Jiaqiang
    Sabatino, Marianna
    Balakumaran, Arun
    Kuznetsov, Sergei
    Klein, Harvey G.
    Robey, Pamela G.
    Stroncek, David
    [J]. BLOOD, 2009, 114 (22) : 20 - 21
  • [24] Natalizumab increases circulating CD34+cells with an impaired functional potential in patients with multiple sclerosis. Bone marrow derived CD34+cells remain unaffected
    Saure, C.
    Zohren, F.
    Bruns, I
    Schroeder, T.
    Caddedu, R. P.
    Fischer, U.
    Kobbe, G.
    Hartung, H. P.
    Kieseier, B.
    Haas, R.
    [J]. ONKOLOGIE, 2010, 33 : 218 - 218
  • [25] Nicotinamide attenuates differentiation and elevates bone marrow homing potential of cultured CD34+cells
    Peled, T.
    Adi, S.
    Peleg, I.
    Rosenheimer, N.
    Fibach, E.
    Nagler, A.
    Peled, A.
    [J]. EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 62 - 62
  • [26] Differentiation of CD34+Cells Into Erythroid Cells by Human Fetal Liver Stromal Cells Expressing Erythropoietin
    Yang Chao
    Ji Lei
    Shi Shuang-Shuang
    Yue Wen
    He Li-Juan
    Nan Xue
    Pei Xue-Tao
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (04) : 381 - 388
  • [27] Relative distribution of different compartments of CD34+cells in the bone marrow of patients with myelodysplastic syndromes
    Matarraz, S.
    Lopez, A.
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Orfao, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 233 - 233
  • [28] Gene therapy for adenosine deaminase deficiency targeting autologous bone marrow CD34+cells
    Hatano, N
    Ohtsu, M
    Sakiyama, Y
    Ariga, T
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 376 - 377
  • [29] Adhesion molecules involved in transendothelial migration of CD34+cells: An in vitro study using a human bone marrow endothelial cell line (HBMEC)
    Imbert, AM
    Reymond, N
    Belaaloui, G
    Lopez, M
    Chabannon, C
    [J]. EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 203 - 203
  • [30] Differential gene expression of bone marrow CD34+cells in early and advanced myelodysplastic syndrome
    Vasikova, A.
    Budinska, E.
    Belickova, M.
    Cermak, J.
    Bruchova, H.
    [J]. NEOPLASMA, 2009, 56 (04) : 335 - 342
12345